After more than twenty years, we’re excited to unveil a new look and logo for the Rivkin Center. We believe the new brand reflects our aspiration to make a bigger impact for more women now and in the future. Our new brand more clearly represents all aspects of our programs: research, education, and high-risk […]
Read More
The Federal Drug Administration (FDA) made an exciting announcement this week with the first approval for PARP inhibitors to be used for patients following their initial diagnosis and treatment to reduce the risk of recurrence. The FDA approved the use of the PARP inhibitor olaparib (Lynparza®) for frontline maintenance therapy for advanced epithelial ovarian, fallopian […]
Read More
The world changed for Bobbie Hinton when her mother, Colleen Kirwin, lost her eight-year battle with ovarian cancer in 2011. Four years later, Bobbie herself was diagnosed with breast cancer. Bobbie and her husband, Dave, are inspired by the work of the Rivkin Center and its fight against two devastating diseases for women: breast cancer […]
Read More
The Rivkin Center’s education program provides free health education workshops across the west coast. Rivkin EDU survivors share their cancer journey with party attendees and help educate women on ovarian and breast health, while instructors educate women about their breast and ovarian health and cancer risks. Say hello to Helen Chen, Rivkin EDU instructor and […]
Read More
The Rivkin Center’s Education Program The Rivkin Center’s Education program provides free health education workshops. Rivkin Edu campus ambassadors are the feet-on-the-ground Rivkin Center representatives at universities across the west coast, helping set up workshops, identify opportunities to reach more students, and so much more. Say hello to Jessica Woods, Rivkin Education ambassador at Arizona […]
Read More
We get it; your annual wellness exam is an appointment you’re eager to rush through. Even so, it is an important step in prevention and early detection of cancer and a time with your doctor that you should take advantage of. Here are seven tips to ensure you’re advocating for your health — and three […]
Read More
You may have read in recent news that a new research study found that daily, low-dose aspirin may lower a woman’s risk of developing ovarian cancer. So does that mean you should start — or change — your aspirin regimen? Dr. Nora Disis, our Medical and Scientific Director and the Director of the University of […]
Read More
What is hereditary breast and ovarian cancer? 10-15% of ovarian cancer and 5-10% of breast cancer are hereditary. To kick off October as Breast Cancer Awareness Month, we’re going to dive into a lesser-discussed topic that bridges the gap between ovarian and breast cancer: hereditary breast and ovarian cancer (HBOC). Many people have a general […]
Read More
My story In January 2017, I went in for my annual gynecological exam. During the exam, my gynecologist noted that my uterus seemed enlarged and, suspecting that I had fibroids, sent me for an ultrasound. While having the ultrasound I watched the monitor trying to decipher the gray blobs I saw, wondering how I’d fit […]
Read More
The Rivkin Center’s Rivkin Education Program The Rivkin Center for Ovarian Cancer’s Education program provides free health education workshops. Rivkin Edu instructors educate women about their breast and ovarian health and cancer risks. Say hello to Lauren Grabowski, Rivkin Edu instructor. About Lauren Where are you from? Vacaville, California (Cowtown!) Where do you live now […]
Read More
The Rivkin Center’s Rivkin Program The Rivkin Center for Ovarian Cancer’s Education program provides free health education workshops across the west coast. Rivkin Edu facilitators share their cancer journey with Rivkin Edu party attendees and help educate women on ovarian and breast health. Say hello to Ilyse Wagner, Rivkin Edu facilitator. About Ilyse Where are […]
Read More
We are thrilled to have Debbie McKenzie as our 2018 SummeRun honoree! Debbie and her family and friends have been supporters of the SummeRun for the past three years and are great friends of the Rivkin Center. We know Debbie’s story will inspire you as you participate in this year’s event! Debbie’s Story Debbie had […]
Read MoreStarting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).
